Pentoxifylline Administration in Hemodialysis Patients
Status:
Unknown status
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess the impact of pentoxifylline administration on the
modulation of hyporesponsiveness to erythropoietin stimulating agents in hemodialysis
patients